Brief: Evotec And Novo Nordisk Enter Into Technology Development Partnership To Support Next-Generation Cell Therapies

Evotec SE

26/09/2024 06:34

Sept 26 (Reuters) - EVOTEC SE  EVTG.DE :
    * EVOTEC AND NOVO NORDISK ENTER INTO TECHNOLOGY DEVELOPMENT
PARTNERSHIP TO SUPPORT NEXT-GENERATION CELL THERAPIES
    * FUNDING TO SUPPORT EVOTEC'S RESEARCH AND DEVELOPMENT IN
GERMANY
AND ITALY
    * NOVO NORDISK HAS OPTION FOR EXCLUSIVE RIGHTS TO
COLLABORATION
RESULTS
    * TO RECEIVE RESEARCH AND DEVELOPMENT FUNDING, UPFRONT,
MILESTONE,
AND ROYALTY PAYMENTS
    * EVOTEC RECEIVES RESEARCH AND DEVELOPMENT FUNDING, AN
UNDISCLOSED
UPFRONT AND POSSIBLE MILESTONE AND ROYALTY PAYMENTS

Source text for Eikon:  ID:nEQbKZdmPa 
Further company coverage:  EVTG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))